Maroo, Anjli <br/><br/>
Bivalirudin in PCI: an overview of the REPLACE-2 trial.  [electronic resource] 

 -  Seminars in thrombosis and hemostasis  Jun 2004 
 - 329-36 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0094-6176 
<br/><br/><label>Standard No.: </label>10.1055/s-2004-831045  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anticoagulants--therapeutic use<br/>Clinical Trials as Topic<br/>Double-Blind Method<br/>Female<br/>Heart Diseases--drug therapy<br/>Heparin--therapeutic use<br/>Hirudins--analogs & derivatives<br/>Humans<br/>Male<br/>Middle Aged<br/>Peptide Fragments--therapeutic use<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Recombinant Proteins--therapeutic use<br/>Thrombin--antagonists & inhibitors<br/>Time Factors<br/>Treatment Outcome